Immune Thrombocytopenia
📧 Sign up to get email alerts when something new happens for Immune Thrombocytopenia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-09-24Clinical Trial Update: Sequential rhTPO and Eltrombopag Following Glucocorticoids for Severe Adult ITP [Phase 4]
Phase 4 clinical trial evaluating sequential treatment with recombinant human thrombopoietin (rhTPO) followed by eltrombopag after glucocort…
-
CLINICAL_TRIALS research · 2025-09-19Clinical Trial Update: Ultrasound to Detect Splenomegally in Patients With Isolated Thrombocytopenia
A clinical trial update describes research using ultrasound to detect splenomegaly in patients with isolated thrombocytopenia, including pri…
-
CLINICAL_TRIALS other · 2025-09-17Clinical Trial Update: Safety Study of CC312 in Autoimmune Disease Patients [EARLY_Phase 1]
Early-phase safety study of CC312 in multiple autoimmune diseases is currently recruiting, sponsored by CytoCares Inc.
-
CLINICAL_TRIALS research · 2025-09-16Clinical Trial Update: An Exploratory Study of CD19/CD22/BCMA CAR-T Cells (BZE2204) in Subjects With Relapsed or Refractory Autoimmune Diseases [EARLY_Phase 1]
An early-phase exploratory study evaluating BZE2204 CAR-T cells targeting CD19/CD22/BCMA for relapsed or refractory autoimmune diseases, cur…
-
CLINICAL_TRIALS withdrawal · 2025-09-16Clinical Trial Update: The Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of HMPL-523 in Adult Subjects With Immune Thrombocytopenia (ITP) [Phase 1]
Phase 1 trial evaluating HMPL-523 for safety, tolerability, PK, and preliminary efficacy in adults with immune thrombocytopenia, which has b…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-09-09Clinical Trial Update: The Combination of ATRA and Eltrombopag as the Treatment of Steroid-resistant/Relapse ITP Based on MSC-C5b-9 [Phase 3]
A Phase 3 trial assessing the combination of all-trans retinoic acid and eltrombopag for steroid-resistant or relapsed immune thrombocytopen…
-
CLINICAL_TRIALS research · 2025-09-08Clinical Trial Update: Vitamin D Satus in Adults With Newly Diagnosed ITP
A clinical trial update indicates a study assessing Vitamin D status in adults with newly diagnosed immune thrombocytopenia (ITP) is not yet…
-
CLINICAL_TRIALS research · 2025-09-08Clinical Trial Update: The Efficacy and Safety of Combined Teriflunomide and High-dose Dexamethasone in Newly Diagnosed Primary Immune Thrombocytopenia (TEMPO-2) [Phase 2]
A Phase 2 clinical trial (TEMPO-2) is evaluating the combination of teriflunomide and high-dose dexamethasone for newly diagnosed primary im…
-
CLINICAL_TRIALS trial_result · 2025-08-26Clinical Trial Update: A Clinical Trial of Chidamide in the Management of Refractory ITP [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating chidamide for immune thrombocytopenia has completed.
-
CLINICAL_TRIALS research · 2025-08-21Clinical Trial Update: Exploring the Efficacy, Safety of a Modified Starting Dosage of Avatrombopag in Immune Throbocytopenia (ITP) - a Pilot Study [Phase 4]
A Phase 4 pilot study is evaluating a modified starting dosage of avatrombopag for immune thrombocytopenia, currently recruiting.
-
CLINICAL_TRIALS withdrawal · 2025-08-11Clinical Trial Update: Teriflunomide Plus High-dose Dexamethasone as First-line Treatment in Newly Diagnosed Primary Immune Thrombocytopenia [Phase 2]
A Phase 2 trial evaluating teriflunomide plus high-dose dexamethasone as first-line therapy for newly diagnosed immune thrombocytopenia has …
-
CLINICAL_TRIALS research · 2025-08-08Clinical Trial Update: Anti CD19/BCMA CAR Gene Therapy for Relapsed/Refractory Immune Thrombocytopenia [NA]
A clinical trial evaluating an anti-CD19/BCMA CAR T-cell therapy for relapsed/refractory immune thrombocytopenia is currently recruiting at …
-
CLINICAL_TRIALS research · 2025-08-07Clinical Trial Update: Inaticabtagene Autoleucel Injection in the Treatment of Refractory Systemic Lupus Erythematosus-related Immune Thrombocytopenia [Phase 1]
Phase 1 clinical trial evaluating inaticabtagene autoleucel for refractory systemic lupus erythematosus-related immune thrombocytopenia is c…
-
CLINICAL_TRIALS research · 2025-08-05Clinical Trial Update: A Clinical Study of NAD in the Treatment of Immune Thrombocytopenia [Phase 1, Phase 2]
Ongoing Phase 1/2 clinical trial in China evaluating nicotinamide adenine dinucleotide (NAD) for immune thrombocytopenia.
-
CLINICAL_TRIALS research · 2025-08-05Clinical Trial Update: Anti-CD38 Antibody Treating Children With Primary Immune Thrombocytopenia (ITP) [Phase 2]
A Phase 2 clinical trial evaluating an anti-CD38 antibody for treating children with primary immune thrombocytopenia is currently recruiting…
-
CLINICAL_TRIALS research · 2025-07-31Clinical Trial Update: Safety, Tolerability, and Efficacy of NVG-2089 in Participants With Immune Thrombocytopenia [Phase 2]
A Phase 2 clinical trial evaluating NVG-2089 for safety, tolerability, and efficacy in immune thrombocytopenia is currently recruiting.
-
CLINICAL_TRIALS safety_alert · 2025-07-30Clinical Trial Update: Eltrombopag Induced Liver Dysfunction During Treatment of Immunethrombocytopenic Purpura [NA]
A clinical trial update reports eltrombopag-associated liver dysfunction observed during treatment of immune thrombocytopenia, highlighting …
-
CLINICAL_TRIALS trial_result · 2025-07-29Clinical Trial Update: Eltrombopag vs Standard Front Line Management for Newly Diagnosed Immune Thrombocytopenia (ITP) in Children [Phase 3]
Phase 3 trial evaluating eltrombopag versus standard frontline management for newly diagnosed immune thrombocytopenia in children has comple…
-
CLINICAL_TRIALS research · 2025-07-24Clinical Trial Update: A Study on the Safety and Efficacy of TQB3473 Tablets in the Treatment of Persistent or Chronic Primary Immune Thrombocytopenia (ITP) in Adults [Phase 2]
Phase 2 clinical trial evaluating the safety and efficacy of TQB3473 tablets for persistent or chronic primary immune thrombocytopenia in ad…
-
CLINICAL_TRIALS trial_result · 2025-07-18Clinical Trial Update: Hetrombopag for Pediatric Patients With Chronic Immune Thrombocytopenia [Phase 3]
This clinical trial update indicates that a Phase 3 study evaluating hetrombopag for pediatric patients with chronic immune thrombocytopenia…
-
CLINICAL_TRIALS research · 2025-07-18Clinical Trial Update: RN1201 Injection in the Treatment of Antibody-Mediated Diseases [Phase 1]
Phase 1 trial update for RN1201 Injection targeting antibody-mediated platelet disorders. The study includes refractory immune-mediated plat…
-
CLINICAL_TRIALS research · 2025-07-17Clinical Trial Update: Longitudinal Cohort Study on Immune Thrombocytopenia Complicated With Acute Ischemic Stroke
A planned longitudinal cohort study examining patients with immune thrombocytopenia complicated by acute ischemic stroke, currently NOT_YET_…
-
CLINICAL_TRIALS trial_result · 2025-07-16Clinical Trial Update: Management of Children With Persistent ITP, A Novel Approach [NA]
This clinical trial update describes ongoing recruitment for a study evaluating a novel management approach for persistent immune thrombocyt…
-
CLINICAL_TRIALS research · 2025-07-16Clinical Trial Update: Longitudinal Observational Study on Immune Thrombocytopenia
This longitudinal observational study at Peking University People's Hospital investigates Immune Thrombocytopenia and is not yet recruiting.
-
CLINICAL_TRIALS research · 2025-07-15Clinical Trial Update: The Combination of Upadacitinib and High-dose Dexamethasone as First-line Treatment in Adult Immune Thrombocytopenia [Phase 2]
Phase 2 clinical trial evaluating the combination of upadacitinib and high-dose dexamethasone as first-line treatment for adults with immune…